Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.92
-0.07 (-0.64%)
At close: Sep 3, 2026, 4:00 PM EDT
10.90
-0.02 (-0.18%)
After-hours: Sep 3, 2026, 5:20 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $678.77 million as of September 3, 2026. Its market cap has increased by 183.58% in one year.
Market Cap
678.77M
Enterprise Value
423.15M
1-Year Change
183.58%
Ranking
Category
Stock Price
$10.92
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $678.77M, an increase of 91.31%. That is a compound annual growth rate of 22.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 678.77M | 252.56% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 711.95M |
| Bright Minds Biosciences | 705.94M |
| Shattuck Labs | 694.01M |
| OmniAb | 686.97M |
| Allogene Therapeutics | 685.80M |
| Gyre Therapeutics | 683.92M |
| CorMedix | 664.87M |
| Valneva SE | 664.34M |